OHSU in the news

After Dobbs, Oregon college students stress privacy concerns

Pamplin Media August 19, 2022
U.S. Rep. Suzanne Bonamici meets with Oregon students and university administrators to discuss privacy concerns post-Dobbs; Michael Walsh says OHSU has students in medical disciplines who are taking rotations across the country — including in states that have criminalized abortion services or are now moving to do so.

Moms Favor Telehealth: Here's Why

Medscape August 19, 2022
A rapid review of more than 44,000 women, led by Amy Cantor, M.D., finds participants were equally satisfied or more satisfied with the quality of maternal care received during online appointments than were mothers who had in-person visits.

Gene therapy in ocular disease spurs excitement with some caution

Healio Women's Health & OB/GYN August 19, 2022
In a story discussing gene therapies in development for macular degeneration, diabetic retinopathy and other vision-related conditions, Andreas Lauer, M.D., says: “Gene therapy has been revolutionary in the ophthalmology field. This is truly an important moment in humankind that we are able to deliver gene therapy in a living human and have that person express a protein that’s important for vision that they have never been able to do int heir life and, as a result, preserve their vision."

BostonGene Computational Tool Reconstructs Tumor Microenvironments

GenomeWeb August 17, 2022
In a GenomeWeb article on a computational tool that has the ability to reconstruct tumor microenvironment, Gordon Mills, M.D., Ph.D., says: "The ability to accurately define cell types from deconvolution of RNA-seq data would represent a major advance in the field. The Kassandra decision tree algorithm was designed and trained on a very large set of RNA-seq data, including data from purified populations that was not available in the development of prior algorithms."

COVID-19 shutdowns caused delays in melanoma diagnoses, study finds

(Coos Bay) The World August 17, 2022
A new study co-authored by OHSU melanoma experts. Sancy Leachman, M.D., Ph.D., chair of the OHSU Department of Dermatology and the director of the OHSU Knight Cancer Institute’s Melanoma Program, co-lead the study in collaboration with Harvard Medical School and Brigham and Women’s Hospital, and colleagues at 12 academic centers with dedicated melanoma clinics across the country.
See more stories